CD4 and autoimmune disease: We found that PD-1-Fc increased the percentage of CD4+IFN-γ+ and CD4+IL-17+ cells (Fig. 3c), suggesting that sPD-1 has the ability to promote Th1/Th17 cells, which are critical pathogenic T cells in autoimmune diseases, including RA.